Abstract

The fundamental hypothesis that drugs may affect memory processing by prolonging transmitter action was tested by extending the time of drug action, using repeated administrations of the cholinergic agonist, arecoline hydrobromide (ARE). The ARE was injected intracerebroventicularly into mice immediately after training (T-maze footshock avoidance) and at 90-min intervals thereafter, for a total of 1, 2, or 3 injections. The results indicate that 1 injection had no effect whereas 3 successive injections significantly improved memory retention test performance. The results confirm the hypothesis being tested; six control groups ruled out other plausible interpretations of the results.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call